XML 22 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities:    
Net income $ 130,099 $ 112,801
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 247,266 244,521
Loss (gain) on sale of depreciable real estate assets 13 (2)
Gain on sale of non-depreciable real estate assets (9,260) (2,911)
Stock compensation expense 8,237 6,987
Amortization of debt premium and debt issuance costs 3,468 (2,969)
Net change in operating accounts and other (11,356) 5,578
Net cash provided by operating activities 368,467 364,005
Cash flows from investing activities:    
Purchases of real estate and other assets (19,596) (110,430)
Capital improvements, development and other (133,354) (126,333)
Distributions from real estate joint ventures 184  
Contributions to affiliates (2,700) (750)
Proceeds from disposition of real estate assets 14,640 16,151
Net cash used in investing activities (140,826) (221,362)
Cash flows from financing activities:    
Proceeds from lines of credit 545,000 355,000
Repayments of lines of credit (1,085,000) (655,000)
Net proceeds from commercial paper 367,000  
Proceeds from notes payable 490,435 397,612
Principal payments on notes payable (303,672) (43,622)
Payment of deferred financing costs (9,048) (3,471)
Distributions to noncontrolling interests (7,886) (7,685)
Distributions paid on common shares/units (218,758) (209,843)
Distributions paid on preferred shares/units (1,844) (1,844)
Net change in other financing activities 2,143 (1,854)
Net cash used in financing activities (221,630) (170,707)
Net increase (decrease) in cash, cash equivalents and restricted cash 6,011 (28,064)
Cash, cash equivalents and restricted cash, beginning of period 51,673 88,867
Cash, cash equivalents and restricted cash, end of period 57,684 60,803
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 40,972 32,610
Restricted cash 16,712 28,193
Cash, cash equivalents and restricted cash, end of period 57,684 60,803
Supplemental disclosure of cash flow information:    
Interest paid 84,972 87,872
Income taxes paid 2,452 2,670
Supplemental disclosure of noncash investing and financing activities:    
Conversion of OP Units to shares of common stock 1,157 3,118
Accrued construction in progress 21,063 22,109
Interest capitalized 1,093 1,283
Fair value adjustment on derivative instruments 1,963 4,597
Limited Partner [Member]    
Cash flows from operating activities:    
Net income 130,099 112,801
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 247,266 244,521
Loss (gain) on sale of depreciable real estate assets 13 (2)
Gain on sale of non-depreciable real estate assets (9,260) (2,911)
Stock compensation expense 8,237 6,987
Amortization of debt premium and debt issuance costs 3,468 (2,969)
Net change in operating accounts and other (11,356) 5,578
Net cash provided by operating activities 368,467 364,005
Cash flows from investing activities:    
Purchases of real estate and other assets (19,596) (110,430)
Capital improvements, development and other (133,354) (126,333)
Distributions from real estate joint ventures 184  
Contributions to affiliates (2,700) (750)
Proceeds from disposition of real estate assets 14,640 16,151
Net cash used in investing activities (140,826) (221,362)
Cash flows from financing activities:    
Proceeds from lines of credit 545,000 355,000
Repayments of lines of credit (1,085,000) (655,000)
Net proceeds from commercial paper 367,000  
Proceeds from notes payable 490,435 397,612
Principal payments on notes payable (303,672) (43,622)
Payment of deferred financing costs (9,048) (3,471)
Distributions paid on common shares/units (226,644) (217,528)
Distributions paid on preferred shares/units (1,844) (1,844)
Net change in other financing activities 2,143 (1,854)
Net cash used in financing activities (221,630) (170,707)
Net increase (decrease) in cash, cash equivalents and restricted cash 6,011 (28,064)
Cash, cash equivalents and restricted cash, beginning of period 51,673 88,867
Cash, cash equivalents and restricted cash, end of period 57,684 60,803
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 40,972 32,610
Restricted cash 16,712 28,193
Cash, cash equivalents and restricted cash, end of period 57,684 60,803
Supplemental disclosure of cash flow information:    
Interest paid 84,972 87,872
Income taxes paid 2,452 2,670
Supplemental disclosure of noncash investing and financing activities:    
Accrued construction in progress 21,063 22,109
Interest capitalized 1,093 1,283
Fair value adjustment on derivative instruments $ 1,963 $ 4,597